BNP PARIBAS ARBITRAGE/CALL/SANOFI/95/0.2/20.09.24 Share Price

Warrant

7ANNB

NLBNPFR1XI54

Market Closed - Euronext Paris 16:53:08 03/07/2024 BST
0.51 EUR -3.77% Intraday chart for BNP PARIBAS ARBITRAGE/CALL/SANOFI/95/0.2/20.09.24
Current month+2.04%
1 month-5.66%
Date Price Change
03/07/24 0.51 -3.77%
02/07/24 0.53 -19.70%
01/07/24 0.66 +34.69%
28/06/24 0.49 +6.52%
27/06/24 0.46 -19.30%

Real-time Euronext Paris

Last update July 03, 2024 at 04:53 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying SANOFI
IssuerLogo Issuer BNP Paribas BNP Paribas
7ANNB
ISINNLBNPFR1XI54
Date issued 03/01/2024
Strike 95
Maturity 20/09/2024 (79 Days)
Parity 5 : 1
Emission price 0.74
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.43
Lowest since issue 0.26
Spread 0.08
Spread %14.55%

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
90.44 EUR
Average target price
108.1 EUR
Spread / Average Target
+19.52%
Consensus
  1. Stock Market
  2. Warrants
  3. 7ANNB Warrant